Điều trị và kết quả của bệnh nhân COVID-19 tại bệnh viện chuyên khoa trong đợt sóng thứ ba: sự gia tăng tuổi và tử vong so với đợt sóng đầu/nhì
Tóm tắt
Từ khóa
Tài liệu tham khảo
World Health Organization. Coronavirus disease (COVID-19) pandemic. https://www.who.int/. Accessed November 25, 2021
Matsui K, Inoue Y, Yamamoto K. Rethinking the current older-people-first policy for COVID-19 vaccination in Japan. J Epidemiol. 2021;31:518–9.
Oda Y, Shiraishi S, Shimada M, et al. Clinical profiles and outcome of patients with COVID-19 in a specialized hospital in Japan. J Anesth. 2021;35:405–11.
Ministry of Health, Labour and Welfare. Situation report. https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou_00006. html. Accessed November 25, 2021
Tanaka H, Hirayama A, Nagai H, et al. Increased transmissibility of the SARS-CoV-2 alpha variant in a Japanese population. Int J Environ Res Public Health. 2018;18:7752.
Karako K, Song P, Chen Y, et al. Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021. Biosci Trends. 2021;15:1–8.
Suehiro K. Preoperative assessment for scheduling surgery during the coronavirus disease pandemic. J Anesth. 2021;35:378–83.
Fujishiro A, Saito T, Asai T. COVID-19: be aware of contaminated airway devices. J Anesth. 2020;34:960–1.
Osaka Prefectural Goverment. About outbreak situation of new coronavirus infection patient. https://www.pref.osaka.lg.jp.e.agb. hp.transer.com/iryo/osakakansensho/happyo.html. Accessed November 25, 2021
Ito J, Seo R, Kawakami D, et al. Clinical characteristics and outcomes of critically ill patients with COVID-19 in Kobe, Japan: a single-center, retrospective, observational study. J Anesth. 2021;35:213–21.
Hattori T, Saito A, Chiba H, et al. Characteristics of COVID-19 patients admitted into two hospitals in Sapporo, Japan: analyses and insights from two outbreak waves. Respir Investig. 2021;59:180–6.
Clinical management of patients with COVID-19: a guide for front-line healthcare workers. version 2.1. https://www.niph.go.jp/h-crisis/wp-content/uploads/2020/07/20200706103735_content_000646531.pdf. Accessed November 25, 2021
National Center for Global Health and Medicine. Report of a multicenter, open-label, randomized phase II study to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19 (RACCO study). https://www.ncgm.go.jp/pressrelease/2020/20201223_1.html. Accessed November 25, 2021
Osaka Institute of Public Health. Reports of confirmed COVID-19 patients in Osaka. http://www.iph.pref.osaka.jp/infection/disease/ corona.html. Accessed November 25, 2021
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.
Terada M, Ohtsu H, Saito S, et al. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021;11:e047007.
Mulder E, Pernett F, Schagatay E. A more holistic view could contribute to our understanding of ‘silent hypoxaemia’ in COVID-19 patients. J Physiol. 2021;599:3627–8.
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052–9.
Vasileiou E, Simpson CR, Shi T, et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet. 2021;397:1646–57.
Our World in Data. Coronavirus (COVID-19) vaccinations. https://ourworldindata.org/covid-vaccinations. Accessed November 25, 2021